Patients treated with a combination of capecitabine and temozolomide had more progression-free survival rates compared to those treated with temozolomide only.
/PRNewswire/ Loki Therapeutics, a company developing next-generation therapeutics that leverage vaccination recall antigens to enhance longevity and treat.
Researchers develop a potential two-in-one pancreatic cancer treatment. Pancreatic cancer is one of the many types of cancer that result in significant deaths with no cure in sight.
The new therapy, which is a combination of three drugs that help boost the body s immune defences against tumors, is likely to enter clinical trials later this year.